major
neutral
epitop
papillomavirus
pv
conformationspecif
fulli
characteris
studi
date
limit
hpv
type
analys
epitop
major
capsid
protein
human
papillomaviru
hpv
type
use
monoclon
antibodi
mab
gener
viruslik
particl
vlp
typespecif
mab
found
neutral
recogn
conformationdepend
epitop
two
mab
direct
conform
epitop
found
crossreact
hpv
type
one
found
crossneutr
crossreact
antibodi
investig
use
wildtyp
vlp
two
mutant
result
obtain
suggest
exist
crossneutr
conform
epitop
ntermin
part
fg
loop
major
capsid
protein
four
crossreact
mab
recogn
epitop
also
locat
ntermin
part
fg
loop
papillomavirus
small
nonenvelop
virus
icosahedr
symmetri
viral
genom
approxim
doublestrand
dna
genom
encapsid
structur
consist
capsom
compos
also
minor
capsid
protein
involv
capsid
structur
exact
interact
locat
relat
fulli
characteris
howev
propos
ratio
immun
selfassembl
vlp
made
induc
neutral
antibodi
confer
typespecif
longlast
protect
differ
anim
model
papillomaviru
infect
recent
year
consider
progress
made
toward
develop
prophylact
human
papillomaviru
hpv
vaccin
prevent
genit
hpv
infect
evid
clinic
protect
recent
demonstr
howev
evid
observ
vaccin
elicit
crossprotect
hpv
type
hpv
vaccin
current
develop
contain
vlp
type
two
type
frequent
associ
cervic
neoplasia
human
papillomaviru
type
frequent
detect
genotyp
cervic
cancer
patient
inclus
correspond
vlp
composit
hpv
vaccin
therefor
consid
linear
conform
epitop
identifi
surfac
hpv
vlp
well
establish
conform
epitop
respons
neutral
antibodi
product
sinc
neutral
epitop
hpv
conformationdepend
aminoacid
composit
surfac
local
fulli
character
studi
mainli
limit
type
antihpv
monoclon
antibodi
gener
protein
differ
human
papillomaviru
type
use
map
neutral
epitop
type
conformationdepend
monoclon
antibodi
epitop
identifi
date
typespecif
found
resid
vlp
surfac
within
hypervari
loop
except
mab
recent
demonstr
bind
ctermin
arm
residu
bind
site
neutral
monoclon
antibodi
rais
vlp
includ
residu
within
de
loop
type
residu
within
bc
ef
loop
type
residu
within
fg
loop
type
one
mab
produc
antibodi
neutral
recogn
conformationdepend
epitop
locat
ef
loop
sinc
fourthmost
preval
hpv
associ
cervic
cancer
gener
murin
mab
hpv
vlp
use
character
antigen
structur
capsid
protein
hpv
vlp
produc
sf
insect
cell
use
recombin
baculovirus
encod
gene
gene
addit
two
mutant
hepat
b
core
hbc
encod
sequenc
within
fg
loop
insert
posit
use
order
locat
crossreact
conform
epitop
sf
cell
maintain
grace
insect
medium
invitrogen
cergi
pontois
franc
supplement
fetal
calf
serum
fc
invitrogen
infect
respect
recombin
baculoviru
construct
incub
c
three
day
post
infect
cell
harvest
vlp
purifi
previous
describ
briefli
cell
resuspend
phosphatebuff
salin
pb
contain
nonidet
pepstatin
leupeptin
sigma
aldrich
saint
quentin
fallavi
franc
allow
stand
min
c
cellular
lysat
centrifug
nuclear
pellet
resuspend
icecold
pb
contain
pepstatin
leupeptin
sonic
sampl
load
cscl
gradient
centrifug
equilibrium
beckman
rpm
h
c
cscl
gradient
fraction
analys
refractometri
correct
cscl
densiti
presenc
protein
electrophoresi
sodium
dodecyl
sulfatepolyacrylamid
gel
sdspage
coomassi
blue
stain
posit
fraction
pool
dilut
pb
pellet
ultracentrifug
beckman
sw
rpm
h
c
vlp
resuspend
nacl
sonic
one
burst
maximum
power
total
protein
content
determin
use
microbca
kit
pierc
ozym
franc
selfassembl
differ
vlp
check
electron
microscopi
purpos
vlp
prepar
appli
carbonco
grid
neg
stain
uranyl
acet
observ
nomin
magnif
jeol
electron
microscop
sixto
eightweekold
femal
balbc
mice
iffa
credo
st
germain
larbresl
franc
immun
intrapod
inject
purifi
vlp
emulsifi
quil
conduct
previous
describ
minor
modif
day
mous
boost
prepar
three
day
thereaft
mice
sacrif
poplit
lymph
node
collect
lymphocyt
collect
perfus
lymph
node
rpmi
medium
invitrogen
cell
wash
rpmi
centrifug
g
min
mix
myeloma
cell
ratio
cell
collect
centrifug
g
min
fusion
perform
previous
describ
hybridoma
cultur
supernat
screen
antibodi
reactiv
intact
denatur
vlp
subsequ
step
subclon
product
ascit
fluid
perform
standard
procedur
subclon
isotyp
use
mous
mab
isotyp
kit
accord
recommend
procedur
sigmaaldrich
prepar
ascit
tetramethyl
pentadecan
sigmaaldrich
inject
periton
caviti
femal
balbc
mice
two
week
later
hybridoma
cell
dilut
rpmi
glutamax
inject
periton
caviti
ascit
fluid
centrifug
g
min
c
store
c
use
mab
purchas
pharmingen
bd
bioscienc
lepontdeclaix
franc
kind
gift
n
christensen
milton
hershey
medic
center
hershey
pa
usa
micropl
maxisorp
nunc
coat
ng
per
well
nativ
denatur
vlp
incub
c
overnight
vlp
dissoci
treatment
carbon
buffer
ph
dithiotreitol
dtt
pb
min
c
two
wash
pbstween
well
block
pb
supplement
fc
h
c
duplic
well
two
test
one
control
incub
hybridoma
cultur
supernat
dilut
dilut
buffer
pb
tween
fc
h
c
plate
wash
four
time
probe
peroxidaseconjug
goat
antimous
ig
fc
sigmaaldrich
dilut
h
c
four
wash
solut
contain
mgml
ophenylenediamin
hydrogen
peroxid
mm
sodium
citrat
mm
na
hpo
ad
reaction
stop
min
h
absorb
read
nm
posit
result
score
differ
od
test
control
well
greater
endpoint
titer
calcul
last
serial
threefold
dilut
yield
posit
result
data
present
mean
two
three
determin
neutral
pseudovirion
antibodi
antibodi
investig
inhibit
gene
transfer
accord
previous
describ
protocol
use
vlp
respect
briefli
cell
cultur
complet
dulbecco
modifi
eagl
medium
invitrogen
dmem
supplement
fc
iuml
penicillin
streptomycin
seed
plate
incub
day
c
thereaft
cell
wash
twice
dmem
medium
vlp
mix
ecorilinear
pcmvluc
plasmid
clontech
ozym
montigni
le
bretonneux
franc
code
luciferas
weight
ratio
incub
room
temperatur
min
quantiti
dnavlp
complex
adjust
give
luciferas
activ
approxim
cp
fifti
hybridoma
supernat
dilut
incomplet
dmem
medium
ad
pseudovirion
incub
c
min
addit
cell
h
c
supernat
remov
complet
dmem
ad
cell
cell
incub
h
c
luciferas
gene
express
measur
luminesc
assay
luciferas
report
gene
assay
constant
light
signal
roch
molecular
biochem
meylan
franc
result
express
percentag
inhibit
luciferas
activ
inhibit
correspond
luciferas
activ
obtain
dna
alon
inhibit
correspond
luciferas
activ
obtain
pseudovirion
antibodi
consid
neutral
inhibit
greater
data
present
correspond
obtain
determin
perform
duplic
end
point
titer
calcul
last
serial
threefold
dilut
inhibit
luciferas
express
seventyon
peptid
overlap
repres
fulllength
amino
acid
sequenc
synthes
ntermin
biotinyl
sgsg
spacer
pepset
mimotop
clayton
victoria
australia
except
first
peptid
synthes
ctermin
biotinyl
spacer
cterminu
twentyon
peptid
overlap
repres
amino
acid
sequenc
ef
loop
fg
loop
protein
also
synthes
synthet
peptid
dilut
pb
ph
bsa
ad
well
streptavidinpreco
plate
mimotop
h
incub
c
wash
pb
tween
plate
block
bsa
pb
h
c
mab
dilut
dilut
buffer
ad
allow
react
h
c
wash
pbstween
peroxidas
conjug
goat
antibodi
murin
igg
sigmaaldrich
dilut
dilut
buffer
ad
plate
incub
h
c
plate
wash
time
peroxidas
activ
measur
reactiv
mab
also
investig
wildtyp
mutant
vlp
purpos
ascit
fluid
dilut
test
simultan
three
vlp
accord
procedur
describ
detect
antibodi
result
mean
determin
result
observ
mutant
adjust
accord
result
observ
mab
subclon
reactiv
hybridoma
eighteen
subclon
select
studi
one
clone
produc
mous
immun
vlp
other
mice
immun
vlp
antibodi
produc
subclon
investig
crossreact
use
vlp
type
neutral
use
pseudovirion
describ
previous
mab
test
elisa
use
intact
denatur
vlp
compos
alon
protein
tabl
none
monoclon
antibodi
identifi
react
vlp
indic
direct
epitop
none
direct
epitop
investig
possibl
hybridoma
produc
antibodi
detect
elisa
use
vlp
test
hybridoma
product
neutral
antibodi
use
pseudovirion
neutral
effect
observ
hybridoma
investig
data
shown
order
detect
crossreact
monoclon
antibodi
also
investig
bind
intact
denatur
vlp
type
fifteen
mab
found
bind
surfac
conform
epitop
bound
intact
denatur
vlp
one
mab
reactiv
linear
epitop
present
surfac
vlp
bound
intact
denatur
vlp
two
mab
recogn
buri
linear
epitop
bound
strongli
denatur
vlp
weakli
nativ
vlp
two
mab
recogn
conform
epitop
crossreact
vlp
type
one
also
reactiv
vlp
three
mab
recogn
linear
epitop
crossreact
vlp
wherea
two
crossreact
vlp
neutral
activ
mab
investig
use
pseudovirion
tabl
neutral
pseudovirion
observ
mab
direct
linear
epitop
mab
direct
typespecif
conform
epitop
found
neutral
reduct
greater
gene
transfer
observ
pseudovirion
found
conform
epitop
crossreact
hpv
type
wherea
crossreact
addit
mab
found
high
neutral
activ
observ
sinc
ratio
neutral
elisa
titer
higher
linear
epitop
local
react
mab
elisa
set
overlap
peptid
span
entir
residu
protein
camvir
mab
three
mab
react
nativ
vlp
also
investig
predict
reactiv
peptid
observ
three
mab
reactiv
conform
epitop
data
shown
mab
recogn
linear
sequenc
lie
amino
acid
tvgesvptdlyikg
gsta
tdlyikgsgstatlansti
protein
recogn
sequenc
elknsviqdgdmvdtgfga
qdgdmvdtgfgamdftalq
none
peptid
reactiv
mab
addit
mab
test
synthet
peptid
span
fg
loop
antibodi
synthet
peptid
span
amino
acid
sequenc
result
obtain
svptdlyik
sequenc
amino
acid
recogn
mab
recogn
mvdtgfgam
sequenc
amino
acid
none
synthet
peptid
investig
reactiv
mab
failur
react
peptid
could
relat
low
reactiv
antibodi
sinc
elisa
titer
fact
mab
crossreact
vlp
prompt
us
compar
bind
antibodi
wildtyp
wt
vlp
bind
vlp
previous
gener
protein
mutant
correspond
insert
hbc
sequenc
within
fg
loop
posit
respect
clearli
evid
affect
insert
hbc
sequenc
fg
loop
fig
howev
mab
reduc
bind
previous
observ
mab
use
control
bind
effici
either
mutant
compar
wildtyp
vlp
antibodi
direct
linear
epitop
bound
similarli
wildtyp
mutant
vlp
gener
panel
mab
reactiv
vlp
screen
mab
crossreact
elisa
neutral
pseudovirion
thirteen
mab
typespecif
recogn
conformationdepend
epitop
sinc
reactiv
lost
capsid
disrupt
five
mab
crossreact
three
recogn
linear
epitop
two
recogn
conform
epitop
find
suggest
vlp
prepar
use
immun
hybridoma
screen
contain
mostli
nondenatur
vlp
sinc
two
mab
recogn
buri
epitop
addit
must
note
mab
direct
protein
produc
could
due
low
proport
protein
capsid
composit
mean
small
proport
epitop
present
surfac
vlp
fact
epitop
immunodomin
possibl
test
use
screen
less
sensit
investig
possibl
hybridoma
produc
antibodi
undetect
elisa
use
vlp
test
hybridoma
product
neutral
antibodi
absenc
neutral
pseudovirion
confirm
antibodi
produc
agreement
previou
studi
show
mani
typespecif
conform
mab
identifi
virusneutr
epitop
observ
typespecif
mab
found
neutral
elisa
reactiv
depend
conform
capsid
addit
neutral
assay
determin
one
crossreact
mab
crossneutr
pseudovirion
mab
recogn
conformationdepend
epitop
result
agreement
observ
christensen
et
al
crossreact
mab
neutral
virion
exist
crossreact
epitop
correl
exist
high
level
crossreact
type
studi
provid
evid
crossneutr
epitop
exist
observ
type
suggest
observ
protein
contain
common
neutral
epitop
howev
ongo
clinic
trial
demonstr
although
high
level
protect
vaccin
type
observ
evid
crossprotect
obtain
agreement
fact
epidemiolog
evid
natur
crossprotect
relat
hpv
type
sinc
hpv
neutral
epitop
conformationdepend
surfac
local
vlp
fulli
character
one
mab
produc
studi
found
recogn
epitop
situat
ef
loop
local
conform
epitop
previous
obtain
investig
reactiv
mab
vlp
insert
foreign
peptid
within
differ
hypervari
loop
protein
hybrid
papillomaviru
vlp
similarli
examin
whether
peptid
insert
fg
hypervari
region
would
disrupt
crossreact
mabbind
vlp
elisa
sinc
five
mab
crossreact
investig
reactiv
wildtyp
vlp
two
mutant
previous
creat
insert
short
heterolog
sequenc
within
fg
loop
protein
posit
contrast
bind
observ
mab
bind
affect
insert
posit
mab
bind
vlp
affect
insert
posit
insert
posit
result
suggest
exist
crossreact
conform
linear
epitop
ntermin
part
fg
loop
howev
insert
local
global
structur
effect
surfac
loop
vlp
loss
bind
pure
indic
specif
conform
epitop
site
addit
identifi
linear
crossreact
epitop
svptdlyik
part
epitop
sequenc
well
conserv
among
high
risk
hpv
sequenc
part
envpddlyikgsg
sequenc
describ
correspond
mab
describ
cason
et
al
part
gtvgenvpddlyik
sequenc
recogn
describ
kulski
et
al
posit
agreement
fact
reactiv
mab
affect
insert
foreign
epitop
posit
epitop
local
nterminu
fg
loop
surfaceexpos
top
also
side
capsom
conclus
map
character
epitop
highrisk
hpv
could
contribut
understand
immunopathobiolog
hpv
infect
could
provid
valuabl
inform
engin
hpv
vaccin
mab
import
tool
attempt
monitor
immun
develop
hpv
vaccin
recipi
character
protect
epitop
virion
mutant
therefor
current
develop
order
investig
whether
typespecif
neutral
mab
direct
fg
loop
observ
